CancerCare's 2016 Patient Access and Engagement Report underscores barriers for patient access to care, as well as communication gaps with care providers, both of which have a significant impact on patient outcomes.
CancerCare, an organization that provides information and support services to cancer patients, has commissioned a report that presents the physical, financial, practical, and informational needs of more than 3000 cancer patients. The 2016 Patient Access and Engagement Report has tried to reflect barriers for patient access to care, as well as communication gaps with care providers, both of which have a significant impact on patient outcomes.
The advisory board that helped develop the report included healthcare providers and leaders within CancerCare. Patients who participated in the survey represented diverse ethnicity, income, education, geography, age, insurance, cancer type, and treatment stage. The following are some of the findings of the study:
Understanding Diagnosis
Treatment Planning
Communication With Care Team
Financial and Insurance Issues
Symptoms, Side Effects, and Quality of Life
Survivorship
“Cancer takes its toll in many ways, some of which last for years and cause debilitating distress for patients and families,” Patricia J. Goldsmith, CEO of CancerCare, said in a statement. “This report, reflecting the input of thousands of patients, sheds light on the important issues affecting patients’ lives during and beyond a cancer diagnosis.”
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen